Measurements, technologies, and standards accelerate the development and translation of regenerative medicine products, including cell and gene therapies. NIST hosts multiple consortia (e.g., Flow Cytometry Standards Consortium [FCSC],1 Genome Editing Consortium,2 Rapid Microbial Testing Methods Consortium3), each addressing a set of specific challenges via a collaborative approach aimed to develop measurement solutions and standards. A major component of NIST consortia is large-scale interlaboratory studies (ILSs) designed to generate data needed to develop more robust protocols, best practices, documentary standards, reference materials, and standard data.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: